Eyenovia to Present at the Ladenburg Thalmann 2018 Healthcare Conference

NEW YORK, Sept. 18, 2018 (GLOBE NEWSWIRE) -- Eyenovia, Inc. EYEN, a biopharmaceutical company developing a pipeline of ophthalmology products utilizing its patented piezo-print technology to deliver microdosed medications topically to the eye, today announced that Dr. Sean Ianchulev, Eyenovia's Chief Executive Officer and Chief Medical Officer, is scheduled to present at the Ladenburg Thalmann 2018 Healthcare Conference on October 2, 2018 at The Sofitel New York Hotel.

Details of the presentation are below:

Event: Ladenburg Thalmann 2018 Healthcare Conference

Date: Tuesday, October 2, 2018

Time: 10:30am ET

Location: Track 3 - St. Germain II

About Eyenovia

Eyenovia, Inc. EYEN is a specialty biopharmaceutical company building a portfolio of next generation topical eye treatments based on its proprietary delivery and formulation platform for microdosing. Eyenovia's pipeline is currently focused on the late-stage development of microdosed medications for myopia progression, glaucoma and other eye diseases.

Company Contact:

Eyenovia, Inc.

John Gandolfo

Chief Financial Officer

jgandolfo@eyenoviabio.com

Investor Contact:

Tram Bui / Alexander Lobo

The Ruth Group

Phone: 646-536-7035/7037

tbui@theruthgroup.com / alobo@theruthgroup.com

Media Contact:

The Ruth Group

Kirsten Thomas

508-280-6592

kthomas@theruthgroup.com